Biocon Malaysia gets UK MHRA approval for new drug product fill-finish unit for insulins

UK regulator approval follows EMA clearances, enabling Biocon’s Malaysia-based fill-finish line to support aseptic packaging and final delivery of Semglee insulin and other biologics